Year: 2026
Type: article
Study design: Observational Study
Abstract: Liquid biopsy is a useful, non-invasive tool that tracks the dynamics of molecular evolution of NSCLC. BIOMETROS is a retrospective and prospective study aimed at evaluating the concordance of liquid biopsy with tissue and its added value in dynamically monitoring the molecular characteristics of NSCLC and their correlation with clinical outcomes in patients (pts) treated with ROS1- and MET-TKIs. Here we present results from the ROS1+ retrospective cohort.
Source: ESMO Open
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
Award: G5430758186
OpenAlex ID: W7138180997
FWCI:
Cites:
Cited by:
Related to:
